- Home
- Software Solutions
- Resources
- Corporate
Protective Effect of Mangafodipir Against Oxaliplatin Neurotoxicity
Sponsors:
| Phases:
| |
| Indications | Acronym: MnDPDP-K04 | |
| ||
Age Groups:
| Gender: Both | |
Names:
| Enrollment: 25 | |
Additional information about NCT00727922.